FIELD: organic chemistry, biochemistry, medicine. SUBSTANCE: invention describes new derivatives of arylsulfonylhydroxamic acid of the formula (I)  where values Ar, R3-R8, Y and X are given in p. 1 of the invention claim. Compounds can be used as inhibitors of matrix metalloproteinases or tumor necrosis factor formation and used for treatment of patients with arthritis, carcinoma, ulcer tissue formation, restenosis, periodontal disease, inherited bullate apidermolysis, scleritis and other diseases exhibiting matrix metalloproteinase activity and AIDS, sepsis, septic shock and other diseases involving tumor necrosis factor formation. EFFECT: enhanced effectiveness of compounds. 12 cl, 6 ex
 where values Ar, R3-R8, Y and X are given in p. 1 of the invention claim. Compounds can be used as inhibitors of matrix metalloproteinases or tumor necrosis factor formation and used for treatment of patients with arthritis, carcinoma, ulcer tissue formation, restenosis, periodontal disease, inherited bullate apidermolysis, scleritis and other diseases exhibiting matrix metalloproteinase activity and AIDS, sepsis, septic shock and other diseases involving tumor necrosis factor formation. EFFECT: enhanced effectiveness of compounds. 12 cl, 6 ex
             
         
            
              
                | Title | Year | Author | Number | 
							
              
                | DERIVATIVES OF ARYLSULFONYLAMINOHYDROXAMIC ACID, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF MATRIX METALLOPROTEINASES AND METHOD OF PATIENT TREATMENT | 1996 | 
										Ral'F P.RobinsonDzhejms P.Ritstsi | RU2145597C1 | 
							
              
                | SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION BASED ON SAID, METHOD OF PATIENT TREATMENT, INTERMEDIATE COMPOUND | 1993 | 
										Dzhen M.BrajtUillard M.Uehlch | RU2130453C1 | 
							
              
                | TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO-[3,4-C]-1,2,4-TRIAZOLO- -[4,3-A]-PYRIDINES, METHOD OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE TYPE IV AND METHOD OF INHIBITION OF TUMOR-SPECIFIC NECROSIS FACTOR PRODUCING | 1996 | 
										Allen Jakob DaplehntirKelvin Kuper | RU2161158C2 | 
							
              
                | PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |  | RU2124016C1 | 
							
              
                | SULFONAMIDES, METHOD OF THEIR SYNTHESIS | 1999 | 
										Andresen Brajan MajklKhammen Filip DitrichKhokinz Dzhouehl Majkl | RU2197479C2 | 
							
              
                | METHOD OF TREATMENT OR PROPHYLAXIS OF MAMMALS AND HUMAN WITH VOMITING USING SOME QUINUCLIDINE, PIPERIDINE, AZANORBORNANE, ETHYLENEDIAMINE DERIVATIVES AND RELATED COMPOUNDS | 1994 | 
										Mehnoj K. DesajDzhon A. Loueh IiiDzhon U. Vatson | RU2135179C1 | 
							
              
                | FLUOROALKOXYBENZYLAMINE DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLES, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF SUBSTANCE P EFFECT IN MAMMALIAN | 1992 | 
										Dzhon Adams Lou IiiTerri Dzhehj Rouzen | RU2114848C1 | 
							
              
                | AMINOSUBSTITUTED PYRAZOLES AND INTERMEDIATE AMINO SUBSTITUTED PYRAZINES | 1993 |  | RU2142455C1 | 
							
              
                | BENZOPYRANE AND BENZOCONDENSED COMPOUNDS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND A METHOD OF INHIBITION | 1995 | 
										Mark A.DombroskiKevin KokhEhntoni Daniehl' Piskop'O | RU2128655C1 | 
							
              
                | STIMULATING AGENTS OF GROWTH HORMONE SECRETION | 1996 | 
										Filip A. KarpinoPol A. Dasil'Va DzhardinBrjus A. LefkerDzhon A. Rehgehn | RU2172742C2 |